Ohio
|
|
1-13292
|
|
31-1414921
|
(State
or other jurisdiction
of
incorporation)
|
|
(Commission
File Number)
|
|
(IRS
Employer
Identification
No.)
|
14111
Scottslawn Road, Marysville, Ohio 43041
|
(Address
of principal executive offices) (Zip Code)
|
(937) 644-0011
|
(Registrant’s
telephone number, including area code)
|
Not
applicable
|
(Former
name or former address, if changed since last report)
|
o |
Written
communications pursuant to Rule 425 under the Securities Act (17 CFR
230.425)
|
o |
Soliciting
material pursuant to Rule 14a-12 under the Exchange Act (17 CFR
240.14a-12)
|
o |
Pre-commencement
communications pursuant to Rule 14d-2(b) under the Exchange Act (17
CFR 240.14d-2(b))
|
o |
Pre-commencement
communications pursuant to Rule 13e-4(c) under the Exchange Act (17
CFR 240.13e-4(c))
|
|
(a)
|
|
Financial
statements of businesses acquired:
|
||
|
|||||
|
|
|
Not
applicable.
|
||
|
|||||
|
(b)
|
|
Pro
forma financial information:
|
||
|
|||||
|
|
|
Not
applicable.
|
||
|
|||||
|
(c)
|
|
Shell
company transactions:
|
||
|
|||||
|
|
|
Not
applicable.
|
||
|
|||||
|
(d)
|
|
Exhibits:
|
Exhibit No.
|
|
Description
|
|||
|
|
|
|||
99.1
|
|
News
Release issued by The Scotts Miracle-Gro Company on July 31,
2008
|
THE
SCOTTS MIRACLE-GRO COMPANY
|
||
|
|
|
Dated:
August 1, 2008
|
By: |
/s/
David C. Evans
|
Printed
Name: David C. Evans
|
||
Title:
Executive Vice President and Chief Financial
Officer
|
Exhibit No.
|
|
Description
|
|
|
|
99.1
|
|
News
Release issued by The Scotts Miracle-Gro Company on July 31,
2008
|
The Scotts Miracle-Gro
Company
|
NEWS
|
· |
Third
quarter sales improve 7%, led by 32% improvement in Global
Professional
|
· |
Global
Consumer sales grow 6% with improvements in both U.S. and
Europe
|
· |
Consumer
purchases at major retailer partners in the U.S. increase
8%
|
· |
Company
reaffirms previous earnings guidance entering fall lawn care
season
|
· |
Adverse
weather conditions could adversely affect our sales and financial
results;
|
· |
Our
historical seasonality could impair our ability to pay obligations
and
operating expenses as they come due and operating
expenses;
|
· |
Our
substantial indebtedness could adversely affect our financial
health;
|
· |
Public
perceptions regarding the safety of our products, particularly
in light of
our recently announced product recalls, could adversely affect
us;
|
· |
Costs
associated with our recently announced product recalls and product
registration issues and the corresponding governmental investigation,
including recall costs, legal and advertising expenses, lost sales
and
potential governmental fines could adversely affect our financial
results;
|
· |
The
loss of one or more of our top customers could adversely affect
our
financial results because of the concentration of our sales to
a small
number of retail customers;
|
· |
The
expiration of certain patents could substantially increase our
competition
in the United States;
|
· |
Compliance
with environmental and other public health regulations could increase
our
cost of doing business; and
|
· |
Our
significant international operations make us more susceptible to
fluctuations in currency exchange rates and to the costs of international
regulation.
|
Three
Months Ended
|
Nine
Months Ended
|
|||||||||||||||||||||
June
28,
|
June
30,
|
%
|
June
28,
|
June
30,
|
%
|
|||||||||||||||||
Footnotes
|
2008
|
2007
|
Change
|
2008
|
2007
|
Change
|
||||||||||||||||
Net
sales
|
$
|
1,170.9
|
$
|
1,098.4
|
7
|
%
|
$
|
2,437.6
|
$
|
2,362.9
|
3
|
%
|
||||||||||
Cost
of sales
|
746.9
|
675.7
|
1,596.9
|
1,516.5
|
||||||||||||||||||
Cost
of sales - product registrations/recalls
|
0.2
|
-
|
22.8
|
-
|
||||||||||||||||||
Gross
profit
|
423.8
|
422.7
|
0
|
%
|
817.9
|
846.4
|
-3
|
%
|
||||||||||||||
%
of sales
|
36.2
|
%
|
38.5
|
%
|
33.6
|
%
|
35.8
|
%
|
||||||||||||||
Operating
expenses:
|
||||||||||||||||||||||
Selling,
general and administrative
|
206.9
|
199.2
|
4
|
%
|
559.6
|
544.4
|
3
|
%
|
||||||||||||||
Impairment
and product registrations/recalls
|
128.9
|
-
|
130.1
|
-
|
||||||||||||||||||
Other
income, net
|
(5.4
|
)
|
(3.6
|
)
|
(9.6
|
)
|
(7.0
|
)
|
||||||||||||||
Total
operating expenses
|
330.4
|
195.6
|
69
|
%
|
680.1
|
537.4
|
27
|
%
|
||||||||||||||
Income
from operations
|
93.4
|
227.1
|
-59
|
%
|
137.8
|
309.0
|
-55
|
%
|
||||||||||||||
%
of sales
|
8.0
|
%
|
20.7
|
%
|
5.7
|
%
|
13.1
|
%
|
||||||||||||||
Costs
related to refinancings
|
-
|
-
|
-
|
18.3
|
||||||||||||||||||
Interest
expense
|
22.1
|
26.2
|
64.6
|
52.3
|
||||||||||||||||||
Income
before taxes
|
71.3
|
200.9
|
-65
|
%
|
73.2
|
238.4
|
-69
|
%
|
||||||||||||||
Income
tax expense
|
48.7
|
71.2
|
49.4
|
84.7
|
||||||||||||||||||
Net
income
|
22.6
|
129.7
|
-83
|
%
|
23.8
|
153.7
|
-85
|
%
|
||||||||||||||
Basic
income per share
|
(1)
|
|
$
|
0.35
|
$
|
2.04
|
-83
|
%
|
$
|
0.37
|
$
|
2.34
|
-84
|
%
|
||||||||
|
||||||||||||||||||||||
Diluted
income per share
|
(2)
|
|
$
|
0.35
|
$
|
1.98
|
-83
|
%
|
$
|
0.36
|
$
|
2.28
|
-84
|
%
|
||||||||
|
||||||||||||||||||||||
Common
shares used in basic income
|
||||||||||||||||||||||
per
share calculation
|
|
64.6
|
63.6
|
2
|
%
|
64.4
|
65.6
|
-2
|
%
|
|||||||||||||
Common
shares and potential common
|
||||||||||||||||||||||
shares
used in diluted income per
|
||||||||||||||||||||||
share
calculation
|
65.3
|
65.4
|
0
|
%
|
65.5
|
67.5
|
-3
|
%
|
||||||||||||||
|
||||||||||||||||||||||
|
||||||||||||||||||||||
Results
of operations excluding restructuring, refinancing
charges, loss on impairment and other charges:
|
||||||||||||||||||||||
Adjusted
net income
|
(4)
|
|
$
|
130.7
|
$
|
129.7
|
1
|
%
|
$
|
151.6
|
$
|
165.5
|
-8
|
%
|
||||||||
|
||||||||||||||||||||||
Adjusted
diluted income per share
|
(2)
(4)
|
|
$
|
2.00
|
$
|
1.98
|
1
|
%
|
$
|
2.31
|
$
|
2.45
|
-6
|
%
|
||||||||
|
|
|||||||||||||||||||||
Adjusted
EBITDA
|
(3)
(4)
|
|
$
|
234.6
|
$
|
244.3
|
-4
|
%
|
$
|
327.7
|
$
|
360.3
|
-9
|
%
|
||||||||
|
||||||||||||||||||||||
|
|
|||||||||||||||||||||
Pro
forma results as if the recapitalization transactionsand
related debt restructuring occurred as of the the
beginning of each fiscal year
|
||||||||||||||||||||||
Pro
forma adjusted net income
|
(4)
(5)
|
|
$
|
151.6
|
$
|
150.3
|
1
|
%
|
||||||||||||||
Pro
forma adjusted diluted income per share
|
(4)
(5)
|
|
$
|
2.31
|
$
|
2.31
|
0
|
%
|
Three
Months Ended
|
||||||||||
June
28,
|
June
30,
|
|||||||||
2008
|
2007
|
%
Change
|
||||||||
Global
Consumer
|
930.1
|
875.4
|
6
|
%
|
||||||
Global
Professional
|
98.7
|
75.0
|
32
|
%
|
||||||
Scotts
LawnService®
|
87.4
|
84.6
|
3
|
%
|
||||||
Corporate
& Other
|
54.7
|
63.4
|
-14
|
%
|
||||||
Consolidated
|
$
|
1,170.9
|
$
|
1,098.4
|
7
|
%
|
Nine
Months Ended
|
||||||||||
June
28,
|
June
30,
|
|||||||||
2008
|
2007
|
%
Change
|
||||||||
Global
Consumer
|
1,898.9
|
1,872.3
|
1
|
%
|
||||||
Global
Professional
|
260.6
|
208.5
|
25
|
%
|
||||||
Scotts
LawnService®
|
157.7
|
144.1
|
9
|
%
|
||||||
Corporate
& Other
|
120.4
|
138.0
|
-13
|
%
|
||||||
Consolidated
|
$
|
2,437.6
|
$
|
2,362.9
|
3
|
%
|
June
28,
|
June
30,
|
September
30,
|
||||||||||
2008
|
2007
|
2007
|
||||||||||
ASSETS
|
||||||||||||
Current
assets
|
||||||||||||
Cash
and cash equivalents
|
$
|
166.0
|
$
|
66.9
|
$
|
67.9
|
||||||
Accounts
receivable, net
|
796.2
|
711.1
|
397.8
|
|||||||||
Inventories,
net
|
474.9
|
432.4
|
405.9
|
|||||||||
Prepaids
and other current assets
|
153.3
|
112.7
|
127.7
|
|||||||||
Total
current assets
|
1,590.4
|
1,323.1
|
999.3
|
|||||||||
Property,
plant and equipment, net
|
355.8
|
364.8
|
365.9
|
|||||||||
Goodwill,
net
|
386.7
|
477.7
|
462.9
|
|||||||||
Other
intangible assets, net
|
377.1
|
418.7
|
418.8
|
|||||||||
Other
assets
|
23.9
|
34.6
|
30.3
|
|||||||||
Total
assets
|
$
|
2,733.9
|
$
|
2,618.9
|
$
|
2,277.2
|
||||||
LIABILITIES
AND SHAREHOLDERS' EQUITY
|
||||||||||||
Current
liabilities
|
||||||||||||
Current
portion of debt
|
$
|
292.1
|
$
|
237.2
|
$
|
86.4
|
||||||
Accounts
payable
|
295.1
|
274.1
|
202.5
|
|||||||||
Other
current liabilities
|
443.8
|
410.0
|
297.7
|
|||||||||
Total
current liabilities
|
1,031.0
|
921.3
|
586.6
|
|||||||||
Long-term
debt
|
1,028.3
|
1,030.1
|
1,031.4
|
|||||||||
Other
liabilities
|
174.8
|
161.4
|
179.9
|
|||||||||
Total
liabilities
|
2,234.1
|
2,112.8
|
1,797.9
|
|||||||||
Shareholders'
equity
|
499.8
|
506.1
|
479.3
|
|||||||||
Total
liabilities and shareholders' equity
|
$
|
2,733.9
|
$
|
2,618.9
|
$
|
2,277.2
|
Three
Months Ended June 28, 2008
|
Three
Months Ended
June
30, 2007 (a)
|
|||||||||||||||
As
Reported
|
Product
Registration/Recalls
|
Impairment
|
Adjusted
|
As
Reported
|
||||||||||||
Net
sales
|
$
|
1,170.9
|
$
|
(5.2
|
)
|
$
|
-
|
$
|
1,176.1
|
$
|
1,098.4
|
|||||
Cost
of sales
|
746.9
|
(0.8
|
)
|
-
|
747.7
|
675.7
|
||||||||||
Cost
of sales - product registrations/recalls
|
0.2
|
0.2
|
-
|
-
|
|
-
|
||||||||||
Gross
profit
|
423.8
|
(4.6
|
)
|
-
|
428.4
|
422.7
|
||||||||||
%
of sales
|
36.2
|
%
|
36.4
|
%
|
38.5
|
%
|
||||||||||
Operating
expenses:
|
||||||||||||||||
Selling,
general and administrative
|
206.9
|
-
|
-
|
206.9
|
199.2
|
|||||||||||
Impairment
and product registrations/recalls
|
128.9
|
5.6
|
123.3
|
-
|
-
|
|||||||||||
Other
income, net
|
(5.4
|
)
|
-
|
-
|
(5.4
|
)
|
(3.6
|
)
|
||||||||
Total
operating expenses
|
330.4
|
5.6
|
123.3
|
201.5
|
195.6
|
|||||||||||
Income
from operations
|
93.4
|
(10.2
|
)
|
(123.3
|
)
|
226.9
|
227.1
|
|||||||||
%
of sales
|
8.0
|
%
|
19.3
|
%
|
20.7
|
%
|
||||||||||
Costs
related to refinancings
|
-
|
-
|
-
|
-
|
-
|
|||||||||||
Interest
expense
|
22.1
|
-
|
-
|
22.1
|
26.2
|
|||||||||||
Income
before taxes
|
71.3
|
(10.2
|
)
|
(123.3
|
)
|
204.8
|
200.9
|
|||||||||
Income
tax expense
|
48.7
|
(4.0
|
)
|
(21.4
|
)
|
74.1
|
71.2
|
|||||||||
Net
income (reported, adjusted and pro forma)
|
$
|
22.6
|
$
|
(6.2
|
)
|
$
|
(101.9
|
)
|
$
|
130.7
|
$
|
129.7
|
||||
Basic
income per share
|
$
|
0.35
|
$
|
(0.10
|
)
|
$
|
(1.58
|
)
|
$
|
2.02
|
$
|
2.04
|
||||
Diluted
income per share
|
$
|
0.35
|
$
|
(0.09
|
)
|
$
|
(1.56
|
)
|
$
|
2.00
|
$
|
1.98
|
||||
Common
shares used in basic income
|
||||||||||||||||
per
share calculation
|
64.6
|
64.6
|
64.6
|
64.6
|
63.6
|
|||||||||||
Common
shares and potential common
|
||||||||||||||||
shares
used in diluted income per
|
||||||||||||||||
share
calculation
|
65.3
|
65.3
|
65.3
|
65.3
|
65.4
|
|||||||||||
Net
income
|
22.6
|
129.7
|
||||||||||||||
Income
tax expense
|
48.7
|
71.2
|
||||||||||||||
Interest
expense
|
22.1
|
26.2
|
||||||||||||||
Product
registrations/recalls
|
(0.4
|
)
|
-
|
|||||||||||||
Costs
related to refinancing
|
-
|
-
|
||||||||||||||
Depreciation
|
13.7
|
12.8
|
||||||||||||||
Amortization,
including marketing fees
|
4.6
|
4.4
|
||||||||||||||
Impairment
of assets
|
123.3
|
-
|
||||||||||||||
Adjusted
EBITDA
|
$
|
234.6
|
$
|
244.3
|
||||||||||||
(a)
- For the three months ended June 30, 2007, there were no items
impacting
comparability.
|
|
Nine
Months Ended June 28, 2008
|
Nine
Months Ended June 30, 2007
|
||||||||||||||||||||||||||
|
As
Reported
|
Product
Registrations/Recalls
|
Impairment
|
Adjusted
|
As
Reported
|
Costs
related to refinancings
|
Adjusted
|
Pro
Forma Adjustments
|
Pro
Forma
Adjusted
|
|||||||||||||||||||
Net
sales
|
$
|
2,437.6
|
$
|
(24.2
|
)
|
$
|
-
|
$
|
2,461.8
|
$
|
2,362.9
|
$
|
-
|
$
|
2,362.9
|
$
|
-
|
$
|
2,362.9
|
|||||||||
Cost
of sales
|
1,596.9
|
(12.8
|
)
|
-
|
1,609.7
|
1,516.5
|
-
|
1,516.5
|
-
|
1,516.5
|
||||||||||||||||||
Cost
of sales - product registrations/recalls
|
22.8
|
22.8
|
-
|
-
|
|
-
|
-
|
-
|
-
|
-
|
||||||||||||||||||
|
||||||||||||||||||||||||||||
Gross
profit
|
817.9
|
(34.2
|
)
|
-
|
852.1
|
846.4
|
-
|
846.4
|
-
|
846.4
|
||||||||||||||||||
%
of
sales
|
33.6
|
%
|
34.6
|
%
|
35.8
|
%
|
35.8
|
%
|
35.8
|
%
|
||||||||||||||||||
|
||||||||||||||||||||||||||||
Operating
expenses:
|
||||||||||||||||||||||||||||
Selling,
general and administrative
|
559.6
|
-
|
-
|
559.6
|
544.4
|
-
|
544.4
|
-
|
544.4
|
|||||||||||||||||||
Impairment
and product registrations/recalls
|
130.1
|
6.8
|
123.3
|
-
|
-
|
-
|
-
|
-
|
-
|
|||||||||||||||||||
Other
income, net
|
(9.6
|
)
|
-
|
-
|
(9.6
|
)
|
(7.0
|
)
|
-
|
(7.0
|
)
|
-
|
(7.0
|
)
|
||||||||||||||
|
||||||||||||||||||||||||||||
Total
operating expenses
|
680.1
|
6.8
|
123.3
|
550.0
|
537.4
|
-
|
537.4
|
-
|
537.4
|
|||||||||||||||||||
|
||||||||||||||||||||||||||||
Income
from operations
|
137.8
|
(41.0
|
)
|
(123.3
|
)
|
302.1
|
309.0
|
-
|
309.0
|
-
|
309.0
|
|||||||||||||||||
%
of
sales
|
5.7
|
%
|
12.3
|
%
|
13.1
|
%
|
13.1
|
%
|
13.1
|
%
|
||||||||||||||||||
|
||||||||||||||||||||||||||||
Costs
related to refinancings
|
-
|
-
|
-
|
-
|
18.3
|
18.3
|
-
|
-
|
-
|
|||||||||||||||||||
Interest
expense
|
64.6
|
-
|
-
|
64.6
|
52.3
|
-
|
52.3
|
23.6
|
75.9
|
|||||||||||||||||||
|
||||||||||||||||||||||||||||
Income
before taxes
|
73.2
|
(41.0
|
)
|
(123.3
|
)
|
237.5
|
238.4
|
(18.3
|
)
|
256.7
|
(23.6
|
)
|
233.1
|
|||||||||||||||
|
||||||||||||||||||||||||||||
Income
tax expense
|
49.4
|
(15.1
|
)
|
(21.4
|
)
|
85.9
|
84.7
|
(6.5
|
)
|
91.2
|
(8.4
|
)
|
82.8
|
|||||||||||||||
|
||||||||||||||||||||||||||||
Net
income (reported, adjusted and pro forma)
|
$
|
23.8
|
$
|
(25.9
|
)
|
$
|
(101.9
|
)
|
$
|
151.6
|
$
|
153.7
|
$
|
(11.8
|
)
|
$
|
165.5
|
$
|
(15.2
|
)
|
$
|
150.3
|
||||||
|
||||||||||||||||||||||||||||
Basic
income per share
|
$
|
0.37
|
$
|
(0.40
|
)
|
$
|
(1.58
|
)
|
$
|
2.35
|
$
|
2.34
|
$
|
(0.18
|
)
|
$
|
2.52
|
$
|
(0.14
|
)
|
$
|
2.38
|
||||||
|
||||||||||||||||||||||||||||
Diluted
income per share
|
$
|
0.36
|
$
|
(0.40
|
)
|
$
|
(1.56
|
)
|
$
|
2.31
|
$
|
2.28
|
$
|
(0.17
|
)
|
$
|
2.45
|
$
|
(0.14
|
)
|
$
|
2.31
|
||||||
|
||||||||||||||||||||||||||||
Common
shares used in basic income
|
||||||||||||||||||||||||||||
per
share calculation
|
64.4
|
64.4
|
64.4
|
64.4
|
65.6
|
65.6
|
65.6
|
63.2
|
||||||||||||||||||||
|
||||||||||||||||||||||||||||
Common
shares and potential common
|
||||||||||||||||||||||||||||
shares
used in diluted income per
|
||||||||||||||||||||||||||||
share
calculation
|
65.5
|
65.5
|
65.5
|
65.5
|
67.5
|
67.5
|
67.5
|
65.2
|
||||||||||||||||||||
|
||||||||||||||||||||||||||||
Net
income
|
23.8
|
153.7
|
||||||||||||||||||||||||||
Income
tax expense
|
49.4
|
84.7
|
||||||||||||||||||||||||||
Interest
expense
|
64.6
|
52.3
|
||||||||||||||||||||||||||
Product
registrations/recalls
|
13.7
|
-
|
||||||||||||||||||||||||||
Costs
related to refinancing
|
-
|
18.3
|
||||||||||||||||||||||||||
Depreciation
|
40.1
|
39.2
|
||||||||||||||||||||||||||
Amortization,
including marketing fees
|
12.8
|
12.1
|
||||||||||||||||||||||||||
Impairment
of Assets
|
123.3
|
-
|
||||||||||||||||||||||||||
|
||||||||||||||||||||||||||||
Adjusted
EBITDA
|
$
|
327.7
|
$
|
360.3
|
(1) |
Basic
earnings per common share is calculated by dividing net income
by average
common shares outstanding during the
period.
|
(2) |
Diluted
income per share is calculated by dividing net income by the average
common shares and dilutive potential common shares (common stock
options,
stock appreciation rights, and restricted stock) outstanding during
the
period.
|
(3) |
"Adjusted
EBITDA" is defined as net income before interest, taxes, depreciation
and
amortization as well as certain other items such as the impact
of
discontinued operations, the cumulative effect of changes in accounting,
costs associated with debt refinancing and other non-recurring,
non-cash
items effecting net income. Adjusted EBITDA is not intended to
represent
cash flow from operations as defined by generally accepted accounting
principles and should not be used as an alternative to net income
as an
indicator of operating performance or to cash flow as a measure
of
liquidity.
|
(4) |
The
Reconciliation of non-GAAP Disclosure Items includes the following
non-GAAP financial measures:
|
(5) |
During
the second quarter of fiscal 2007, Scotts Miracle-Gro completed
a
significant recapitalization plan. The objective of this plan,
announced
on December 12, 2006, was to return $750 million to the Company's
shareholders. This was accomplished via a share repurchase that
totaled
$245.5 million, or 4.5 million shares, which was completed via
a modified
Dutch auction tender offer on February 14, 2007, and a special
one-time
cash dividend of $8.00 per share, totaling $508.0 million, which
was paid
on March 5, 2007 to shareholders of record as of February 26, 2007.
|
Fiscal
2007
|
|||||||
Q1
|
Q2
|
||||||
Incremental
interest on recapitalization borrowings
|
$
|
13.1
|
$
|
8.7
|
|||
New
credit facility interest rate differential
|
1.0
|
0.5
|
|||||
Incremental
amortization of new credit facility fees
|
0.2
|
0.1
|
|||||
Pro
forma incremental interest from recapitalization
|
$
|
14.3
|
$
|
9.3
|
|||
Year-to-date
incremental interest
|
$
|
23.6
|
|||||
Common
shares and potential common shares used
|
|||||||
in
diluted income per share calculation
|
67.2
|
67.8
|
|||||
Incremental
impact of repurchased shares
|
(4.5
|
)
|
(2.7
|
)
|
|||
Incremental
impact on potential common shares
|
-
|
0.1
|
|||||
Pro
forma diluted shares
|
62.7
|
65.2
|
|||||
Year-to-date
pro forma diluted shares
|
65.0
|